Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis

  Free Subscription

Articles published in
AIDS
    October 2026
  1. BERENGUER J, Ryan P, Lutz T, Martin-Carbonero L, et al
    Adherence to European AIDS clinical society hepatitis B management guidelines in people with HIV: real-world evidence from Spain and Germany.
    AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004635.
    >> Share

    September 2026
  2. BERENGUER J, Ryan P, Ramos-Ruperto L, Martin-Carbonero L, et al
    Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV.
    AIDS. 2026 Sep 2. doi: 10.1097/QAD.0000000000004614.
    >> Share

    August 2026
  3. LAPADULA G, Soria A, Puoti M, Bonfanti P, et al
    Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIV.
    AIDS. 2026;40:1053-1066.
    >> Share

    May 2026
  4. MCFARLANE WJ, Flemming JA, Martinez-Cajas JL, Peng Y, et al
    Liver disease risk attributable to HCV, HIV, and HCV-HIV coinfection: an interaction analysis.
    AIDS. 2026 May 26. doi: 10.1097/QAD.0000000000004555.
    >> Share

    April 2026
  5. SOUDEYNS H
    High risk of reacquisition of hepatitis C virus infection in people with HIV with continued risk behavior.
    AIDS. 2026;40:519-521.
    >> Share

    March 2026
  6. CHALOUNI M, Torgersen J, Rentsch CT, Van Santen DK, et al
    Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIV.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004499.
    >> Share

  7. MCFARLANE WJ, Brogly SB, Flemming JA, Martinez-Cajas J, et al
    HIV-sex interaction effect on risk of hepatitis C-related cirrhosis, decompensation, and hepatocellular carcinoma.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004501.
    >> Share

    November 2025
  8. HAGE K, Carson J, Hosseini-Hooshyar S, Sacks-Davis R, et al
    Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies.
    AIDS. 2025 Nov 17. doi: 10.1097/QAD.0000000000004408.
    >> Share

    October 2025
  9. TODESCO E, Valantin MA, Akhavan S, Rouget R, et al
    Acute hepatitis B infections among PWH treated with 2-drug regimen: can we trust the vaccination status?
    AIDS. 2025;39:1845-1847.
    >> Share

    September 2025
  10. MARTIN-CARMONA J, Corona-Mata D, Tellez F, Navarrete Lorite MN, et al
    Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis.
    AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004357.
    >> Share

  11. DIETERICH DT, Brunet L, Hsu RK, Mounzer K, et al
    Tenofovir interruption among people with HIV and HBV: HBV monitoring and risk of HBV reactivation and hepatitis flare.
    AIDS. 2025 Sep 19. doi: 10.1097/QAD.0000000000004353.
    >> Share

    August 2025
  12. BANI-SADR F, Wood BR
    Hepatitis B core antibody positivity and risk of hepatitis B reactivation following switch of antiretroviral therapy.
    AIDS. 2025;39:1481-1483.
    >> Share

    June 2025
  13. HAGE K, Boyd A, Davidovich U, Generaal E, et al
    The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the pre-randomization phase of a clinical trial.
    AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004265.
    >> Share

    May 2025
  14. MEZZADRI L, Soria AG, Ranzani A, Malandrin S, et al
    Hepatitis B core antibody positivity is not associated with risk of transaminase elevation following switch to dual antiretroviral therapy.
    AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004227.
    >> Share

    February 2025
  15. CHALOUNI M, Van Santen DK, Berenguer J, Jarrin I, et al
    Time to direct-acting antivirals initiation and liver-related events in people with HIV and Hepatitis C virus.
    AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004161.
    >> Share

    July 2024
  16. MATHUR P, Ramadhani HO, Kaplan R, Stafford KA, et al
    Interferon-free hepatitis C treatment increases a surrogate of atherosclerotic cardiovascular disease risk in Black veterans living with HIV.
    AIDS. 2024;38:1437-1439.
    >> Share

    March 2024
  17. FLYNN PM, Bhagani S
    Elimination of perinatal transmission of hepatitis B: lessons learned from women with HIV-HBV coinfection.
    AIDS. 2024;38:421-422.
    >> Share

    December 2023
  18. FILIP I
    Moving beyond the guidelines to improve detection of viral hepatitis and linkage to care.
    AIDS. 2023 Dec 4. doi: 10.1097/QAD.0000000000003807.
    >> Share

    October 2023
  19. LARTEY M, Ganu VJ, Tachi K, Yang H, et al
    Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and HBV viral suppression.
    AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003764.
    >> Share

  20. BHATTACHARYA D, Guo R, Tseng CH, Emel L, et al
    Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-saharan Africa, HPTN 046- a post-hoc analysis.
    AIDS. 2023 Oct 18. doi: 10.1097/QAD.0000000000003752.
    >> Share

  21. MPEBE GGA, Phinius BB, Mutenga S, Baruti K, et al
    Hepatitis B surface antigen loss in chronic hepatitis B virus and HIV-1 Co-Infections individuals in Botswana.
    AIDS. 2023 Oct 16. doi: 10.1097/QAD.0000000000003753.
    >> Share

  22. GANDHI MM, Nguyen KL, Lake JE, Liao D, et al
    Proprotein convertase subtisilin/kexin 9 (PCSK9) levels decline with HCV therapy in people with HIV/HCV and correlate with inflammation.
    AIDS. 2023 Oct 2. doi: 10.1097/QAD.0000000000003739.
    >> Share

    September 2023
  23. KILLION JA, Magana C, Cepeda JA, Vo A, et al
    Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation.
    AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003718.
    >> Share

    July 2023
  24. MUULA GK, Bosomprah S, Sinkala E, Nsokolo B, et al
    HBV viral replication markers and hepatic fibrosis in untreated chronic HBV infection with and without HIV coinfection in Zambia.
    AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003659.
    >> Share

    March 2023
  25. IZQUIERDO MIGUEL R, Rava M, Moreno-Garcia E, Blanco JR, et al
    HIV medical care interruption among people living with HIV in Spain, 2004-2020.
    AIDS. 2023 Mar 21. doi: 10.1097/QAD.0000000000003552.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016